Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-14 Option Award |
2025-02-19 8:16 pm |
N/A 2035-02-14 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
22,640 | $0 | 22,640 (Direct) |
View |
| 2025-01-21 Option Award |
2025-01-22 4:05 pm |
N/A 2026-07-28 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
70,106 | $0 | 70,106 (Direct) |
View |
| 2025-01-03 Option Award |
2025-01-07 6:39 pm |
N/A 2035-01-03 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
833,290 | $0 | 833,290 (Direct) |
View |
| 2024-07-16 Option Award |
2024-07-18 5:18 pm |
N/A 2031-07-16 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-30 Option Award |
2023-07-05 9:11 pm |
N/A 2030-06-30 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
6,667 | $0 | 6,667 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:00 pm |
N/A 2029-06-24 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-25 Option Award |
2021-06-29 7:10 pm |
2022-06-25 2028-06-25 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
22,677 | $0 | 22,677 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-29 9:52 pm |
2021-12-22 2030-12-22 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
6,825 | $0 | 6,825 (Direct) |
View |
Ownership |
2020-12-22 8:41 pm |
2019-07-29 2026-07-28 |
Inhibikase Therapeutics Inc. | IKT | Freeman Roy Lester Director |
0 | $0 | 131,122 (Direct) |
View |